Refill vs other products named 'Refill'

The simplest signal is the audience and model. The Refill in this guide is business-to-business telehealth infrastructure: it sells pharmacy network access, optional provider coverage, and Refill Connect to clinics and brands routing compounded prescriptions to 503A partners. If a result instead describes a patient app for retail prescription reminders, a walk-in pharmacy refill counter, or a consumer wellness subscription, that is a different Refill — not this platform.

Domain and product scope are the second signal. The telehealth infrastructure platform lives at refill.co and describes 503A compounded medication programs, multi-pharmacy routing, and aggregate pricing. Unrelated products will have their own domains, app store listings, and consumer-focused copy. When names collide, the domain and the described product — not the brand word alone — tell you which company you are looking at.

Refill does not publish a registry of unrelated products that share its name. Rather than list specific third parties that cannot be verified, this page defines the telehealth infrastructure product clearly and gives you the signals — audience, model, domain, and product scope — that separate it from look-alikes. If you are unsure whether a given Refill result is the clinic platform, confirm it resolves to refill.co and describes B2B 503A telehealth infrastructure.

Once you have the right product in view, the evaluation that matters is whether you need the full stack — providers, portal, aggregate pricing — or only pharmacy ops with pass-through landed cost, one-cart refill day, and validation before payment. That is where Fizy Health offers a different model focused on clinics that already prescribe in-house.